Search hospitals > Washington > Bellevue
Overlake Medical Center
Claim this profileBellevue, Washington 98004
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Tumors
175 reported clinical trials
5 medical researchers
Summary
Overlake Medical Center is a medical facility located in Bellevue, Washington. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Tumors and other specialties. Overlake Medical Center is involved with conducting 175 clinical trials across 357 conditions. There are 5 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, Kathleen Gibson, MD, and John A. Keech.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 positive
HER2 negative
ER positive
Top PIs
John A. EllertonOptumCare Cancer Care at Fort Apache4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
148 reported clinical trials
226 drugs studied
Alan K. IkedaAlliance for Childhood Diseases/Cure 4 the Kids Foundation7 years of reported clinical research
Expert in Tumors
Expert in Leukemia
52 reported clinical trials
109 drugs studied
Kathleen Gibson, MDLake Washington Vascular3 years of reported clinical research
Studies Varicose Veins
Studies Venous Insufficiency
9 reported clinical trials
17 drugs studied
John A. KeechMultiCare Auburn Medical Center9 years of reported clinical research
Studies Breast Cancer
Studies Ovarian Cancer
3 reported clinical trials
12 drugs studied
Clinical Trials running at Overlake Medical Center
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Bladder Carcinoma
Cancer
Gastric Cancer
Renal Cell Carcinoma
Pancreatic Cancer
Esophageal Cancer
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Chemotherapy Reduction After Surgery
for Breast Cancer
This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab and pertuzumab are both a form of "targeted therapy" because they work by attaching themselves to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When these drugs attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving paclitaxel, trastuzumab, and pertuzumab may enable fewer chemotherapy drugs to be given without compromising patient outcomes compared to the usual treatment.
Recruiting1 award Phase 227 criteria
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Overlake Medical Center?
Overlake Medical Center is a medical facility located in Bellevue, Washington. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Tumors and other specialties. Overlake Medical Center is involved with conducting 175 clinical trials across 357 conditions. There are 5 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, Kathleen Gibson, MD, and John A. Keech.